Experience
Kura Oncology Announces Global Strategic Collaboration With Kyowa Kirin
November 20, 2024
Cooley advised clinical-stage biopharmaceutical company Kura Oncology (Nasdaq: KURA) on its global strategic collaboration with Kyowa Kirin to develop and commercialize ziftomenib, Kura’s selective oral menin inhibitor that is being investigated for the treatment of acute myeloid leukemia and other hematologic malignancies.
Related contacts
Related Practices & Industries
AGS Announces Definitive Agreement to Be Acquired by Brightstar Capital Partners for $1.1 Billion
May 9, 2024
Cooley advised PlayAGS, a global gaming supplier of high-performing slots, tables and interactive products, on its definitive agreement to be acquired by the affiliates of Brightstar Capital Partners for $1.1 billion.
Related contacts
Related Practices & Industries
CallTower Receives Investment From BV Investment Partners
November 16, 2023
Cooley advised CallTower, an international leader in delivering cloud-based, enterprise-class communications, contact center and collaboration solutions, on its investment from BV Investment Partners.
Related contacts
Related Practices & Industries
General Catalyst Leads Helsings 209 Million Euro Series B Financing
September 14, 2023
Cooley advised General Catalyst Partners, a venture capital firm providing early-stage and growth equity investments, as the lead investor in Helsing’s 209 million euro Series B financing.
Related contacts
Related Practices & Industries
Sprout Social Acquires Tagger Media
August 4, 2023
Cooley advised Sprout Social, a social media management software company, on its $140 million acquisition of Tagger Media, a top influencer marketing platform, and a concurrent $100 million secured debt facility, which will be partially used to fund the acquisition.
Related contacts
Related Practices & Industries
Admissions and credentials
Brussels, Belgium
Spain